Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Preliminary results
Quarterly results
MARAVAI LIFESCIENCES HOLDINGS, INC. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS"
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT",
"Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition William “Trey” Martin, III assumes the role of Maravai’s CEO Carl Hull to continue to serve as Executive Chairman"
07/20/2023 8-K Quarterly results
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS"
04/20/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/13/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/28/2023 10-K Annual Report for the period ended December 31, 2022
02/22/2023 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS"
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 7.9% stake in Maravai LifeSciences Holdings Inc. Class A
02/08/2023 SC 13G/A MASSACHUSETTS FINANCIAL SERVICES CO reports a 9.9% stake in MARAVAI LIFESCIENCES HOLDINGS INC
12/01/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Maravai LifeSciences Announces Updated CEO Leadership Transition Plans"
10/19/2022 8-K Quarterly results
10/03/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EMPLOYMENT AGREEMENT",
"MARAVAI LIFESCIENCES HOLDINGS, INC. 2020 OMNIBUS INCENTIVE PLAN",
"MARAVAI LIFESCIENCES HOLDINGS, INC. 2020 OMNIBUS INCENTIVE PLAN",
"MARAVAI LIFESCIENCES HOLDINGS, INC. 2020 OMNIBUS INCENTIVE PLAN",
"AMENDMENT TO EMPLOYMENT AGREEMENT",
"Maravai LifeSciences Announces CEO Leadership Transition -William “Trey” Martin, III appointed to succeed Carl Hull as Chief Executive Officer - Hull to Serve as Executive Chairman of the Board of Directors"
09/06/2022 SC 13G/A MASSACHUSETTS FINANCIAL SERVICES CO reports a 10.6% stake in MARAVAI LIFESCIENCES HOLDINGS INC
09/06/2022 SC 13G/A MASSACHUSETTS FINANCIAL SERVICES CO reports a 10.6% stake in MARAVAI LIFESCIENCES HOLDINGS INC
08/05/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS"
07/11/2022 SC 13G/A FMR LLC reports a 3% stake in MARAVAI LIFESCIENCES HOLDINGS INC
05/16/2022 8-K Quarterly results
05/06/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/05/2022 8-K Quarterly results
Docs: "MARAVAI LIFESCIENCES REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS"
04/14/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/01/2022 10-K Annual Report for the period ended December 31, 2021
02/23/2022 8-K Quarterly results
02/14/2022 SC 13G/A D1 Capital Partners L.P. reports a 0% stake in Maravai LifeSciences Holdings, Inc.
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2022 SC 13G/A VANGUARD GROUP INC reports a 8% stake in Maravai LifeSciences Holdings Inc. Class A
02/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2022 SC 13G MASSACHUSETTS FINANCIAL SERVICES CO reports a 6.1% stake in MARAVAI LIFESCIENCES HOLDINGS INC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy